ADMA (ADMA Biologics, Inc.) — Stock Analysis, Catalysts & AI Research

ADMA Biologics, Inc.

$9.84

The Read: 4% following Q1 2026 results due to revenue decline, lowered outlook, and securities fraud probes over channel stuffing.

ADMA

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

ADMA Biologics, Inc.

$9.84

Health CareBiotechnology

The Read: 4% following Q1 2026 results due to revenue decline, lowered outlook, and securities fraud probes over channel stuffing.

ADMA

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Start your free trial to unlock active Expected Moves for ADMA

Expected Moves

ADMA Biologics, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Start your free trial to unlock active Expected Moves for ADMA

Expected Moves

ADMA Biologics, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow